Some patients also experience diminished gastrointestinal side effects (such as nausea) after several months of treatment, which may have initially contributed to reduced food intake
Overall, this study hints at the possibility of considering anti-diabetic drugs with weight loss-inducing effects, especially GLP-1 receptor agonists, for potential repurposing opportunities in MS, the researchers wrote.
However, from an integrative health standpoint, theres more to sustainable weight loss than simply taking a shot once a weekthough these medications can be a game-changer, its crucial to take a whole-person approach and work with a specialist on an ongoing basis
Highlights : One of the first GLP-1 drugs, effective for blood glucose control but less commonly used today due to newer options with greater weight-loss benefits
Tian Y et al
We found patients in Alabama, Texas and Missouri